908 Devices Expands Scientific Advisory Board, Creates Dedicated Proteomics Panel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/30/2026
- Crude Inventory Fell 7.2 Million Barrels Last Week - EIA
- SoFi Technologies (SOFI) Tops Q2 EPS by 1c ; Offers Guidance
- Wall Street closes down sharply after Fed holds rates unchanged
- How will the S&P 500 react to today’s FOMC? JPM lays out the playbook
- Grant Thornton Advisors to buy CBIZ in $5 billion deal, expand US accounting reach
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
- After-Hours Stock Movers: GOOGL, TSLA, NOW, IBM, TXN, MOH, URI
908 Devices Inc. (MASS) PT Lowered to $45 at Stifel
August 4, 2021 1:34 PM EDTStifel analyst Daniel Arias lowered the price target on 908 Devices Inc. (NASDAQ: MASS) to $45.00 (from $55.00) while maintaining a Buy rating.
The analyst commented, "2Q21 was strong with revenues of $8.3 mn coming above consensus and the company's first guidance raise giving us... More
